Harilalith Kovvuri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Harilalith Kovvuri has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Nagendra Boopathy Senguttuvan
Department of Cardiology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India
3 shared publications - Judah Nijas Arul
Department of Cardiology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India
2 shared publications Ramesh Sankaran
Department of Cardiology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India
2 shared publicationsSadhanandham Shanmugasundaram
Department of Cardiology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India
2 shared publications- Abinayaa Rajkumar
Department of Medical Biochemistry, Taramani Campus, University of Madras, Chennai 600113, Tamil Nadu, India
1 shared publication Adhiya N.S.S
Cardiac Care Centre, Sri Ramachandra Institute of Higher Education and Research, Chennai, India
1 shared publication
Latest Publications
- Open Access
- 7 July 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1131-1134
The Standard Modifiable Cardiovascular Risk Factor Paradox Revisited
- 7 July 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1131-1134
Open AccessThe Standard Modifiable Cardiovascular Risk Factor Paradox Revisited
- Open Access
Redox Imbalance and Genetic Mutations in Heart Failure: Synergistic Mechanisms and Therapeutic Strategies
Heart failure (HF) is a significant global health challenge, with rising prevalence and a complex, multifactorial pathophysiology. Emerging evidence suggests that disruptions in redox signaling pathways and genetic mutations play critical, synergistic roles in the development and progression of HF. This comprehensive review synthesizes current knowledge on how redox imbalance and genetic alterations interact to drive cardiac dysfunction and critically evaluates the therapeutic strategies targeting these mechanisms. We begin by introducing the basic concepts of redox biology and its role in maintaining cardiac homeostasis. Next, we examine the specific redox signaling pathways and genetic mutations implicated in HF pathogenesis, highlighting the latest mechanistic insights and findings from human studies. The complex interplay between redox dysregulation and genetic factors is explored, including their synergistic effects, compensatory mechanisms, and illustrative case studies. We also review current therapeutic strategies aimed at restoring redox balance and correcting underlying genetic mutations, discussing their progress and limitations. Finally, we present the latest research advances, identify critical knowledge gaps, and propose future directions for both basic and translational research. Understanding the redox–genetic axis is key to developing novel, targeted therapies to address the growing HF epidemic.
Open AccessRedox Imbalance and Genetic Mutations in Heart Failure: Synergistic Mechanisms and Therapeutic Strategies
Heart failure (HF) is a significant global health challenge, with rising prevalence and a complex, multifactorial pathophysiology. Emerging evidence suggests that disruptions in redox signaling pathways and genetic mutations play critical, synergistic roles in the development and progression of HF. This comprehensive review synthesizes current knowledge on how redox imbalance and genetic alterations interact to drive cardiac dysfunction and critically evaluates the therapeutic strategies targeting these mechanisms. We begin by introducing the basic concepts of redox biology and its role in maintaining cardiac homeostasis. Next, we examine the specific redox signaling pathways and genetic mutations implicated in HF pathogenesis, highlighting the latest mechanistic insights and findings from human studies. The complex interplay between redox dysregulation and genetic factors is explored, including their synergistic effects, compensatory mechanisms, and illustrative case studies. We also review current therapeutic strategies aimed at restoring redox balance and correcting underlying genetic mutations, discussing their progress and limitations. Finally, we present the latest research advances, identify critical knowledge gaps, and propose future directions for both basic and translational research. Understanding the redox–genetic axis is key to developing novel, targeted therapies to address the growing HF epidemic.
- 8 May 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (13) , 1688-1690
Inefficient Maximal Hyperemic Response Following Intravenous Adenosine in Polycythemia
- 8 May 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (13) , 1688-1690
Inefficient Maximal Hyperemic Response Following Intravenous Adenosine in Polycythemia